Product Program year 2021 Source: CMS Open Payments

Oct-Maestro2

Device Ophthalmic Device

PDI 04562123289251

Open in the dashboard

General payments

$24,500

5 payments

Research payments

0 payments

Through program year 2021, $24,500 in general payments and $0 in research payments were reported against Oct-Maestro2 (Ophthalmic Device).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row

Year	Kind	Amount	Payments
2021	General	$24,500	5

Breakdown

Who paid General payments · program year 2021

Topcon Medical Systems, Inc. $24,500 5 payments

Top recipients General payments · program year 2021

Michael Chaglasian Optometrist · Chicago, IL $15,000 61% · 2 payments
Timothy Bossie Optometrist · Boston, MA $5,500 22% · 1 payment
Nadia Waheed Uveitis and Ocular Inflammatory Disease · Boston, MA $2,500 10% · 1 payment
Stephen Lipsky Pediatric Ophthalmology and Strabismus Specialist · Peachtree Corners, GA $1,500 6% · 1 payment

Each share is of general payments naming this product in 2021.

Specialties paid General payments · program year 2021

Optometrist $20,500 84% · 2 practitioners
Uveitis and Ocular Inflammatory Disease Ophthalmology $2,500 10% · 1 practitioner
Pediatric Ophthalmology and Strabismus Specialist Ophthalmology $1,500 6% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2021

Illinois $15,000 61% · 1 recipient
Massachusetts $8,000 33% · 2 recipients
Georgia $1,500 6% · 1 recipient

Each share is of general payments naming this product in 2021 where a state was reported.

Records

5 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.